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60 The Journal of Thoracic and Cardiobjective: Device closure of secundum atrial septal defects is sometimes needed in
oung children; however, little is known about the safety and outcome of this
rocedure in infants. In this study, the safety and efficacy of secundum atrial septal
efect closure with the Amplatzer septal occluder (AGA Medical Corp, Golden
alley, Minn) was evaluated in patients less than 1 year of age.
ethods: Between July 1999 and September 2006, atrial septal defect closure with
he Amplatzer septal occluder was attempted in 15 infants at our institution. The
atients ranged in age from 0.5 to 11.9 months (mean  standard deviation; 8.2 
.7 months) in the percutaneous group and from 2.2 to 3.4 months (2.9  0.6
onths) in the peratrial group. Their weights ranged from 3.8 to 8.3 kg (5.5  1.7 kg)
nd from 3.0 to 4.0 kg (3.4  0.6 kg) in each group, respectively. The indica-
ions for atrial septal defect closure were failure to thrive, significant chamber
nlargement, hemodynamically significant shunts, and prehepatic transplantation.
he size of the defect as measured by intracardiac echocardiography (n  3)
r transesophageal echocardiography (n  12) ranged from 2.0 to 16 mm (8.0 
.4 mm).
esults: The pulmonary/systemic flow ratio ranged from 1.0 to 9.0 (2.8  2.0).The
evice was successfully placed in 14 of 15 infants. The size of the Amplatzer septal
ccluder device implanted ranged from 4 to 20 mm (10.1  4.3 mm). It was
ercutaneously deployed in 11 of 14 patients and by the hybrid or peratrial approach
open chest off-pump) in 3 of 14 infants. In infants who had a successful attempt
n  14), the complete closure rates at 24 hours and 1 year were 86% and 100%,
espectively. In 3 of 15 infants, minor complications occurred: transient arrhythmias
n  2) and blood transfusion (n  1). One patient had a major complication
vascular intimal injury with thrombosis of the inferior vena cava). One patient with
own syndrome died 6 weeks later of progressive pulmonary hypertension. The
ollow-up time ranged from 0.6 to 6.9 years (3.2 1.9 years). At follow-up, clinical
evelopment and growth improved in all children with failure to thrive, and all
entilator-dependent children could be weaned shortly after closure of the atrial
eptal defect.
onclusion: Device closure of atrial septal defects is an effective and fairly safe
lternative to surgery in infants. Hybrid or peratrial closure is also an alternative to
ercutaneous closure in the very small infant.
ecundum atrial septal defect (ASD) is a common congenital heart disease and
accounts for approximately 6% to 10% of all congenital cardiac def1
Since 1976, when King and associates2 attempted the first transcathete
losure of a secundum ASD in humans, device closure has evolved significantly.
he Amplatzer septal occluder (ASO) (AGA Medical Corp, Golden Valley, Minn)
as become the most commonly used device. Previous reports have shown that it is
asy to use and has a high success rate.3-6 The alleged advantages of percutaneous
vascular Surgery ● October 2007
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Dlosure over surgical closure as shown by some studies in
lder children and adults include avoidance of cardiopul-
onary bypass, decreased complication rates, shorter h
ital stays,7,8 and greater cost-effectiveness.9
Although device closure is now a widely acceptable
lternative to surgery in most patients with secundum ASD,
t is still considered technically challenging in infants, with
ittle known about its safety and feasibility in those less than
year of age. Previous studies involving device closure of
ecundum ASDs have included predominantly adults and
lder children,7,10,11 with no reports involving a large se
f very young infants.
The aim of this study was to evaluate the feasibility,
fficacy, and safety of device closure of secundum ASDs in
nfants using either the percutaneous or the hybrid (pera-
rial) approach.
aterials and Methods
evice
he ASO was used in all patients. A full description of this device
as been reported previously.3,5 In brief, the device is made 
.004- to 0.0075-inch nitinol wire. It consists of two expandable
iscs connected by a 4-mm long waist, the diameter of which
orresponds to the size of the device, which is available in sizes
anging from 4 to 38 mm.
atient Population
etween July 1999 and September 2006, 15 infants (9 boys and 6
irls) underwent an attempt at closure of their secundum ASDs
ith the ASO by either the percutaneous or the hybrid technique.
outine informed consent was initially obtained from the parents
efore any kind of intervention and approval for chart review was
btained by the institutional review board. The infants ranged in
ge from 0.5 to 11.9 months (mean  standard deviation, 8.2 
.7 months) in the percutaneous group and from 2.2 to 3.4 months
2.9 0.6 months) in the peratrial group. The weights ranged from
.8 to 8.3 kg (6.0  1.4 kg) and from 3.0 to 4.0 kg (3.4  0.6 kg)
n each group, respectively (Table 1). The indications for 
losure included failure to thrive with significant chamber enlarge-
ent and/or hemodynamically significant shunts despite medical
herapy in 11 patients. In 2 patients who were undergoing hepatic
ransplantation, device closure of a patent foramen ovale was
erformed to prevent any paradoxical emboli during inferior vena
ava unclamping. Two other patients had significant chronic lung
Abbreviations and Acronyms
ASD atrial septal defect
ASO Amplatzer septal occluder
ICE  intracardiac echocardiography
TEE  transesophageal echocardiography
VSD ventricular septal defectisease secondary to prematurity and were ventilator-dependent. t
The Journal of Thoracicrotocol
ll procedures were performed with the patient under general
nesthesia with either continuous transesophageal (TEE, n  12)
r intracardiac echocardiographic (ICE, n  3) guidance. The
etailed protocol of percutaneous device closure has been reported
reviously.3,12 Full assessment of the defect and surrounding r
as performed. In the percutaneous cases, a hemodynamic assess-
ent of the degree of left-to-right shunt was performed. Heparin
as administered routinely in all patients. Angiography in the right
pper pulmonary vein was performed to assess the size and loca-
ion of the defect. Balloon sizing was not performed. The maxi-
um size of the ASD was chosen as determined by echocardiog-
aphy. Antibiotic prophylaxis was given during the procedure and
hen at 8 hours and 16 hours later. All patients were placed on an
spirin regimen of 5 mg/kg for 6 months after the procedure. All
atients had a chest radiograph, electrocardiogram, and echocar-
iogram at 24 hours, 1, 6, and 12 months after the procedure, and
early thereafter.
The peratrial approach was used in 3 patients (patients 13, 14,
nd 15) owing to the size of the infant (3.5 kg) in 2 cases and
ecause of simultaneous perventricular ventricular septal defect
VSD) closure in 1 case (Figure 1). This approach involv
inimal lower sternotomy that was performed after full evaluation
f the ASD by TEE. The right atrial wall was then punctured with
n 18-gauge needle through which a 0.035-inch wire was passed to
he left atrium. The dilator and the introducing sheath were placed
n the mid left atrium. Injecting agitated saline bubbles into the left
trium confirmed the position of the sheath. The ASO was then
oaded into the sheath and the left disc was deployed first, followed
y the right disc. The position of the device was then confirmed by
EE before the device was released.
tatistical Analysis
alues are given as mean  standard deviation and range.
esults
able 1 demonstrates the clinical data of all 15 pat
here were 12 percutaneous and 3 peratrial (hybrid) proce-
ures performed. Delivery of devices was successful in all
xcept 1 patient (patient 12), in whom multiple attempts at
eploying the device failed owing to deficient inferoposte-
ior rim. The size of the ASD as measured by echocardiog-
aphy (TEE or ICE) ranged from 2 to 16 mm (8.0  4.4
m). One patient (patient 15 in Table 1) had a fenes
SD with one large ASD measuring 8 mm and a few
maller ones. There was a left-to-right shunt across the ASD
n all patients. The pulmonary/systemic flow ratio ranged
rom 1.0 to 9.0 (2.8  2.0). The size of the ASO device
mplanted ranged from 4 to 20 mm (10.1  4.3 mm). The
ize of the sheaths used to release the device ranged from 5F
o 8F. In the 3 infants in whom ICE was used, an additional
F sheath was placed in the left femoral vein. In the percu-
aneous cases, the fluoroscopy time and the total procedure
ime ranged from 5.7 to 56.0 minutes (20.5 13.8 minutes)
nd from 48.0 to 222.0 minutes (110.3  53.1), respec-
ively. In those who had a successful attempt, the immediate
and Cardiovascular Surgery ● Volume 134, Number 4 961
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Domplete closure rate was 92.9% overall (90.9% in the
ercutaneous group and 100% in the peratrial group). At 24
ours, 2 of 14 patients in whom devices were deployed
ad small residual shunts. However, the closure rate was
00% at 12 months’ follow-up after the procedure in both
roups.
Additional interventional procedures were performed
n 4 of 15 patients during the same session (patients 2, 8,
1, and 15). Those included patent ductus arteriosus coil
cclusion (n  1), aortic balloon angioplasty for reco-
rctation (n  1), and muscular VSD closure (n  2). In
ddition, 1 patient (patient 6 in Table I) had an el
hysiologic study subsequent to the intervention because
f a history of atrioventricular node re-entrant tachycar-
ia. Cardiopulmonary bypass was not needed in any of
he peratrial cases.
Table 1 also lists the adverse events related to the
edure or to the device. Minor complications were encoun-
ered in 3 patients. These included transient arrhythmias in
patients and blood loss during access requiring blood
ransfusion in 1 patient. One patient had a major complica-
ion (vascular intimal injury in the right femoral vein). This
esulted in swelling of the right leg owing to thrombus
ormation in the femoral and iliac veins with extension into
he inferior vena cava. This patient required heparin therapy
or a few days followed by warfarin for 6 months. The swelling
as disappeared; however, the inferior vena cava remains
hrombosed. One patient who had Down syndrome died 6
eeks after the procedure of progressive pulmonary hyperten-
ion and right ventricular failure. All other 13 patients did well.
ABLE 1. Clinical data of infants undergoing ASD closure
atient
o.
Age
(mo) Gender
Weight
(kg)
1 5.6 M 5.6 Down syndrome,
2 10.9 M 4.0 Secundum ASD,
3 7.8 M 5.8 Alagille syndrome
4 11.5 M 8.3 Secundum ASD
5 0.5 M 4.6 Critical AS s/p an
6 7.8 F 6.9 Secundum ASD,
7 11.2 F 7.2 Secundum ASD
8 2.2 M 3.8 Coarctation of ao
AoV, small LV
9 7.9 M 5.1 Secundum ASD
0 11.9 F 7.0 Secundum ASD
1 10.6 F 6.5 Secundum ASD,
2 10.1 M 7.5 Down syndrome,
3 2.2 M 3.0 BPD, secundum
4 3.1 F 3.1 BPD, secundum
5 3.4 F 4.0 Secundum ASD,62 The Journal of Thoracic and Cardiovascular Surgery ● Octo-
-
o date, there have been no episodes of endocarditis, throm-
oembolism, device disruption or erosion, valve regurgitation,
r permanent rhythm disturbances.
ollow-up and Clinical Condition
he mean follow-up period was 3.2  1.9 years (range
.6-6.9 years). All children with feeding problems and fail-
re to thrive gained weight and were above the 10th per-
entile for weight on last follow-up. All patients who were
upported by mechanical ventilation were weaned from the
entilator shortly after device closure. In particular, the 2
remature patients with significant bronchopulmonary dys-
lasia were also successfully extubated within 10 days of
he procedure. One patient (patient 5, Table I), who 
orn with critical aortic valve stenosis and somewhat mar-
inal left ventricular size, initially underwent successful
alloon aortic valvuloplasty. However, he continued to be
entilator-dependent with heart failure resulting from sig-
ificant left-to-right shunt at the ASD level. He was suc-
essfully extubated within 24 hours after ASD closure in the
atheterization laboratory and was discharged home in good
ondition. Another patient (patient 8) was status post sur-
ical repair of severe coarctation of the aorta. However, he
emained in heart failure owing to significant shunt via an
SD. After device closure, he was weaned off all medica-
ions and was discharged home. One patient with Down
yndrome died in our series (patient 1). That patient was a
½-month-old boy who had heart failure owing to a signif-
cant left-to-right shunt via the ASD. During the cardiac
atheterization, the pulmonary artery pressure was elevated
Diagnosis Qp/Qs
ASD size
(mm)
ndum ASD, pulmonary hypertension 2.6 7.3
branch PA stenosis 2.3 10.0
S, PFO 1.3 2.0
2.4 15.0
lasty, PDA, secundum ASD 9.0 9.0
T 1.5 5.0
2.0 12.0
/p repair, subvalvular AS, bicuspid 1.0 4.0
2.7 12.0
2.3 14.8
ple mVSDs 3.6 10.0
ndum ASD 2.3 16.0
7.0
5.5
8.0, 5.0, 2.0secu
PDA,
, PP
giop
AVNR
rta s
multi
secu
ASD
ASD
mVSDber 2007
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Dt near systemic levels with a pulmonary/systemic flow ratio
f 2.6 and a pulmonary vascular resistance of 5.9 units in
oom air. We believed that closure of the ASD was indi-
ated. The defect was closed completely with an 8-mm
evice. However, the patient continued to have right ven-
ricular enlargement and the pulmonary artery pressure con-
inued to increase as evaluated by the tricuspid regurgitation
et. Six weeks after closure, he died of severe heart failure.
utopsy revealed complete closure of the defect and that the
evice was far from vital structures (pulmonary veins,
uperior vena cava, and the atrioventricular valves). His-
opathologic examination of the lungs revealed severe pul-
onary vascular obstructive disease, consistent with Heath-
dwards grade III-IV.
In addition, we evaluated the growth of the atrial septum
n some of our patients as they grew (Figure 2). The r
he device to the atrial septum was calculated at the time of
he procedure and then at 1-year follow-up with the 4-chamber
pical view by transthoracic echocardiography. As is shown
n Figure 2, there is a trend for this ratio to decrease a
nfants grow older. Thus, although the device is signifi-
antly large compared with the atrial septum at the time of
losure, the septum grows significantly and the device size
ecomes less concerning.
iscussion
atients with secundum ASD are usually asymptomatic
uring the first few years of life. Occasionally, however,
hose patients are seen in infancy with signs and symptoms
f congestive heart failure,13 frequent respiratory infec-
ABLE 1. Continued
Device size
(mm)
Additional interventional
procedures Approach
Sheath
(F) (
8.0 None PC 2
12.0 PDA coil occlusion PC 7 1
4.0 None PC 5 1
20.0 None PC 8 2
11.0 None PC 7
5.0 EP study PC 6 1
12.0 None PC 8
6.0 Aortic balloon angioplasty PC 5 2
13.0 None PC 8 3
14.0 None PC 8 1
12.0 4 mVSD device closure PC 8 5
NA None PC 8 1
7.0 None PA 7
6.0 None PA 7
11.0 mVSD device closure PA 7
SD, Atrial septal defect; Qp/Qs, pulmonary/systemic flow ratio; FT, fluoros
rteriosus; PA. peratrial; PPS, peripheral pulmonary stenosis; AS, aortic ste
achycardia; EP, electrophysiologic; AoV, aortic valve; LV, left ventricle
ronchopulmonary dysplasia.
The Journal of Thoracicof
ese
ions,14 and failure to thrive.15 Although most centers ad-
ocate elective closure of moderate-to-large ASDs between
 and 6 years of age,16,17 there is no general agreement 
anaging those patients who are referred in infancy, and
ignificant debate remains as to the optimal timing as well
s the mode of closure of ASDs in infancy. Although
urgical closure of ASD has a low perioperative mortality
nd morbidity, it is still associated with a cosmetic disad-
antage and a longer hospital stay compared with device
losure.7 In addition, although atrial septal defects m
lose spontaneously during the first few years of life18,19
ome have been shown to enlarge with time.20 Therefore,
e elected to study the efficacy and safety of device closure
n those infants who are symptomatic or have other noncar-
iac indications for closure. To our knowledge, this is the
argest series in the literature of infants undergoing device
losure of secundum ASD.
Few clinical studies in the literature have addressed the
roblem of symptomatic secundum ASD in infants. Most
re publications reporting on the outcome of surgical clo-
ure in small series of patients.15,21-24 A study by Parvath
nd associates25 evaluated the outcomes of surgical closu
f ASD in 18 children under 2 years of age. It showed
ncouraging results good enough that the group recom-
ended early closure of ASD in symptomatic infants. In
hat study, 4 of 18 infants had pulmonary complications.
ammers and coworkers26 reported on the surgical closu
f secundum ASD in 24 symptomatic infants less than 1
ear of age and showed significant improvement in growth
nd development on follow-up of these patients, except for
PT (min)
Shunt by echo: Immediate/
24 h/1 mo/1 y Complications
120.0 C/C Died
105.0 C/C/C/C Bleeding, transfused
63.0 C/C/C/C None
96.0 C/C/C/C None
68.0 SS/SS/SS/C None
195.0 C/C/C/C Arrhythmia, hypotension
48.0 C/SS/C/C None
107.0 C/C/C/C None
136.0 C/C/C/C IVC intimal injury
62.0 C/C/C/C None
222.0 C/C/C/C None
102.0 C/C/C/C Surgical closure, none
C/C/C/C Intermittent heart block
C/C/C/C None
C/C/C/C None
time; PT, procedure time; PC, percutaneous; C, closed; PDA, patent ductus
; s/p, status post; SS, small shunt; AVNRT, atrioventricular node re-entrant
, inferior vena cava; mVSD, muscular ventricular septal defect; BPD,FT
min)
0.5
8.0
0.7
0.6
8.5
7.6
5.7
2.5
6.9
1.0
6.0
8.2
copy
nosis
; IVCand Cardiovascular Surgery ● Volume 134, Number 4 963
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Dinfant with Down syndrome who died later of severe
ulmonary hypertension. More recently, a study by Vogel
nd colleagues27 reported the results of percutaneous c-
ure of secundum ASD in 12 symptomatic patients less than
years of age with a mean age of 1.5  0.4 (range 0.8-1.8
ears) using the ASO device. Only 5 of 12 patients in that
tudy weighed less than 10 kg. Although that study showed
hat the procedure could be successfully achieved, the suc-
ess rates were lower than in older patients and 2 patients
eeded the device to be removed surgically due to continued
arge residual shunt.
In our series, device closure was successful in 14 of 15
atients. In 1 patient in whom TEE showed possible appro-
riate rims for device closure, ICE documented deficient
nferoposterior rims; device closure was unsuccessful de-
pite multiple attempts owing to prolapse of the device into
Figure 1. TEE images in a 3.4-month-old infant who und
A, Aneurysmal atrial septum with a large 8-mm defec
B, Guide wire passing through the right atrial free wall
delivery sheath positioned from the right atrial free wa
of an 11-mm Amplatzer septal occluder (ASO) is deploy
right atrial disc (arrow) deployed. F, Final image aft
position. TEE, transesophageal echocardiographic; LA,he right atrium. The patient underwent surgical closure p
64 The Journal of Thoracic and Cardiovascular Surgery ● Octoith no complications. In those who had a successful at-
empt, closure rates were very encouraging: 86% at 24 hours
nd 100% at 1-year follow-up. This result compares favor-
bly with closure rates of 98.5% at 1-year follow-up re-
orted in older children and adults.7 In 1 patient, the devi
rolapsed through the defect and a larger sheath was needed
o recapture the device and to implant a larger size occluder.
nly 1 patient had a technical difficulty, in which the device
ould not be seated well owing to a deficient inferior rim;
he device was recaptured and the patient was sent for
urgical closure at a later date.
In our patients, 5F to 8F sheaths were used to deliver the
SO devices. In 2 patients, a 5F sheath was used and in 5
thers an 8F sheath was required. Only 1 patient, in whom
n 8F sheath was used to deliver a 13-mm device (delivered
ith an 8F Judkins right coronary guide catheter to prevent
ent peratrial atrial septal defect (ASD) device closure.
rge arrow) and smaller fenestrations (small arrows).
e arrow) and across the defect (small arrow). C, Short
o the left atrial cavity across the ASD. D, The left disc
the left atrial cavity (arrow). E, Connecting waist and
th discs were deployed demonstrating good device
atrium; RA, right atrium.erw
t (la
(larg
ll int
ed in
er bo
Leftrolapse of the left atrial disc into the right atrium), had a
ber 2007
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Dascular complication with injury to the intima of the infe-
ior vena cava (see above).
In the percutaneous cases, the ASO was delivered
hrough femoral access in 10 instances. In 1 patient (patient
) in whom both femoral veins were thrombosed, the trans-
epatic approach was used to deliver a 6-mm ASO device
ith no complications.
In most of our patients, ASD closure was done routinely
nder TEE guidance. ICE was used in 3 patients with no
omplications (patients 10, 11, and 12). It has been shown
n previous reports that ICE provided better imaging for
ecundum ASD and the left atrium and that its use as a
uiding imaging tool for device closure resulted in no
ignificant adverse events in patients weighing less than 15
g.4 In the patient in whom device closure was unsucce
patient 12), we believe ICE was superior to TEE in delin-
ating the rims of the defect, especially the inferoposterior
ims, to guide device closure.
The peratrial (hybrid) technique was used in 3 infants
n our series. The advantage of this approach compared
ith the classic surgical approach is avoidance of car-
iopulmonary bypass that could be associated with sig-
ificant morbidity in premature patients with severe bron-
hopulmonary dysplasia (2 patients in this series). In
ddition, unlike the percutaneous technique, the peratrial
igure 2. Graph showing the growth of the atrial septum in some
f our patients at time of procedure (point 1) and at 1 year
ollow-up (point 2). The ratio of the device to the atrial septum
as calculated with the 4-chamber apical view by transthoracic
chocardiography.pproach provides some advantages: it preserves the fem- i
The Journal of Thoracicral vessels and provides a perpendicular angle to the
trial septum as opposed to the sharp angle through the
VC as in the transcatheter closure, which may result in
rolapse of the left atrial disc into the right atrium. The
ybrid approach rather than the percutaneous approach
as used in these cases owing to the size of the infants
3.5 kg) in 2 patients and because of the simultaneous
erventricular muscular VSD closure in 1 patient. All 3
atients had complete closure immediately after device
mplantation and at 1-year follow-up.
This series demonstrates encouraging results with an
cceptable incidence of complications related to the proce-
ure or device implantation. Only 1 patient died in our
eries, and his death was not procedure or device related.
hat patient clearly met the criteria to close the defect;
owever, perhaps a fenestrated device would have been a
etter consideration.
Minor complications occurred in 3 of 14 (21.4%) pa-
ients in our study, 2 of which were related to transient
rrhythmias. This is higher than the rate of minor mor-
idity of 17.8% reported with surgical closure and of
.2% reported with device closure in older children and
dults.3 One of these patients who had arrhythmia, h-
ver, was known to have atrioventricular node re-entrant
achycardia. One patient who underwent peratrial device
losure (patient 13) had transient heart block during
evice manipulation and it resolved at the end of the
rocedure.
Device embolization was not encountered in our se-
ies. The risk for this complication was reported to be
bout 1.1%.3 We believe that more experience in us
he ASO device in young infants will make this technical
omplication less frequent. It is important to mention,
owever, that the ability to retrieve the device might be
ore challenging in infants, especially that large sheaths
ould be required.
Last, as mentioned earlier, all infants thrived well after
evice closure and their weight was above the 10th percen-
ile on the latest follow-up, proving that these defects were
he cause for the failure to thrive.
tudy Limitation
ike any retrospective study, there is bias associated with
ata collection and the incomplete data of some patients.
lthough this report presents the largest series in the liter-
ture of infants less than 1 year of age undergoing device
losure of secundum ASD, the number of patients included
s still relatively small, particularly those patients undergo-
ng peratrial closure, because this is not a commonly en-
ountered indication. In addition, longer follow-up is still
eeded to determine the long-term safety of device closure
n these patients.
and Cardiovascular Surgery ● Volume 134, Number 4 965
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Donclusions
ur results demonstrate that device closure of ASDs is an
ffective and fairly safe alternative to surgery in infants.
eratrial closure is also an effective alternative approach to
ercutaneous closure in very small infants and allows avoid-
nce of cardiopulmonary bypass. Closure of ASDs should
ot be postponed to older age in those infants who are
ymptomatic despite medical therapy. The long-term safety
f this procedure is still to be determined as these children
ontinue to grow.
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